Investor News: Deadline upcoming in Settlement in the Lawsuit against BioScrip Inc (NASDAQ: BIOS)

BioScrip Inc Logo

A deadline is coming up on July 12, 2016 in the settlement reached in the securities class action lawsuit filed on behalf of investors in NASDAQ: BIOS shares between November 9, 2012 and November 6, 2013. Investors who purchased a significant amount of shares of BioScrip Inc (NASDAQ: BIOS) between …

Read More »

Investor News: Investigation over potential Wrongdoing at Lion Biotechnologies Inc (NASDAQ:LBIO)

Lion Biotechnologies Inc Logo

An investigation for investors in NASDAQ:LBIO shares was announced over potential breaches of fiduciary duties by certain officers and directors at Lion Biotechnologies. Investors who purchased shares of Lion Biotechnologies Inc (NASDAQ:LBIO) and currently hold any of those Lion Biotechnologies shares have certain options and should contact the Shareholders Foundation …

Read More »

Investor News: LGL Group Inc (NYSEMKT:LGL) faces Investigation

LGL Group Inc Logo

An investigation for investors in NYSEMKT:LGL shares was announced over potential breaches of fiduciary duties by certain directors at LGL Group Inc. Investors who purchased shares of LGL Group Inc (NYSEMKT:LGL) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554. The investigation …

Read More »

Investor News: Mirati Therapeutics, Inc. (NASDAQ:MRTX) under Investigation over possible Violations of Securities Laws

Mirati Therapeutics, Inc Logo

An investigation for investors in NASDAQ:MRTX shares was announced concerning potential securities laws violations in connection certain financial statements. Investors who purchased shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554. The investigation by a law …

Read More »

Investor News: Lawsuit against directors of La Quinta Holdings Inc (NYSE:LQ) filed

La Quinta Holdings  Logo

An investor in NYSE:LQ shares filed a lawsuit against certain La Quinta Holdings directors over alleged breaches of fiduciary duties. Investors who are current long term investors in La Quinta Holdings Inc (NYSE:LQ) shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – …

Read More »

Investor News: Investigation for Investors in shares of Zosano Pharma Corp (NASDAQ:ZSAN) announced

Zosano Pharma Corp Logo

Zosano Pharma Corp is under investigation concerning potential Securities Laws violations. The investigation was announced for investors in NASDAQ:ZSAN shares in connection certain financial statements made by the specialty pharmaceutical company. Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN), have certain options and should contact the Shareholders Foundation at …

Read More »

Investor News: Lawsuit in effort to Halt the Takeover of Krispy Kreme Doughnuts (NYSE:KKD)

Krispy Kreme Doughnuts Logo

An investor in NYSE:KKD shares filed a lawsuit in effort to halt the proposed takeover of Krispy Kreme Doughnuts. Investors who purchased shares of Krispy Kreme Doughnuts (NYSE:KKD) and currently hold any of those NYSE:KKD shares have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) …

Read More »

Investor News: Asterias Biotherapeutics Inc (NYSEMKT:AST) faces Investigation over possibleWrongdoing

Asterias Biotherapeutics Inc Logo

An investigation for investors in NYSEMKT:AST shares was announced over potential breaches of fiduciary duties by certain directors at Asterias Biotherapeutics. Investors who purchased shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554. The investigation by …

Read More »

Investor News: Infinity Pharmaceuticals Inc. (NASDAQ:INFI) under Investigation

Infinity Pharmaceuticals Inc Logo

An investigation for investors in NASDAQ:INFI shares was announced over potential breaches of fiduciary duties by certain officers and directors at Cambridge, MA based biopharmaceutical company Infinity Pharmaceuticals. Investors who purchased shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and currently hold any of those NASDAQ:INFI shares have certain options and should …

Read More »